# | Title | Journal | Year | Citations |
---|
1 | Angiogenesis and invasion in glioma | Brain Tumor Pathology | 2011 | 226 |
2 | The expression of matrix metalloproteinase-2 and-9 in human gliomas of different pathological grades | Brain Tumor Pathology | 2003 | 181 |
3 | Genetic profile of astrocytic and oligodendroglial gliomas | Brain Tumor Pathology | 2011 | 146 |
4 | Genetic landscape of meningioma | Brain Tumor Pathology | 2016 | 118 |
5 | Molecular pathogenesis of IDH mutations in gliomas | Brain Tumor Pathology | 2012 | 115 |
6 | Immunohistochemical analysis of the mutant epidermal growth factor, ΔEGFR, in glioblastoma | Brain Tumor Pathology | 2004 | 112 |
7 | Pathological review of late cerebral radionecrosis | Brain Tumor Pathology | 2008 | 110 |
8 | Morphological and flow cytometric analysis of cell infiltration in glioblastoma: a comparison of autopsy brain and neuroimaging | Brain Tumor Pathology | 2010 | 102 |
9 | Fluorescence-guided resection of metastatic brain tumors using a 5-aminolevulinic acid-induced protoporphyrin IX: pathological study | Brain Tumor Pathology | 2007 | 96 |
10 | Detection of IDH1 mutation in human gliomas: comparison of immunohistochemistry and sequencing | Brain Tumor Pathology | 2011 | 96 |
11 | Frequent IDH1/2 mutations in intracranial chondrosarcoma: a possible diagnostic clue for its differentiation from chordoma | Brain Tumor Pathology | 2012 | 83 |
12 | Bevacizumab for malignant gliomas: current indications, mechanisms of action and resistance, and markers of response | Brain Tumor Pathology | 2017 | 82 |
13 | Histone deacetylase inhibitors such as sodium butyrate and trichostatin A induce apoptosis through an increase of the bcl-2-related protein Bad | Brain Tumor Pathology | 2001 | 81 |
14 | Recurrence and regrowth of benign meningiomas | Brain Tumor Pathology | 2009 | 80 |
15 | The 2017 WHO classification of pituitary adenoma: overview and comments | Brain Tumor Pathology | 2018 | 77 |
16 | Expression and quantitative analysis of matrix metalloproteinase-2 and-9 in human gliomas | Brain Tumor Pathology | 2004 | 76 |
17 | Blood–brain barrier and blood–cerebrospinal fluid barrier in normal and pathological conditions | Brain Tumor Pathology | 2016 | 76 |
18 | New WHO classification of pituitary adenomas (4th edition): assessment of pituitary transcription factors and the prognostic histological factors | Brain Tumor Pathology | 2018 | 71 |
19 | Multivoxel proton MRS for differentiation of radiation-induced necrosis and tumor recurrence after gamma knife radiosurgery for brain metastases | Brain Tumor Pathology | 2006 | 70 |
20 | Malignant transformation of meningeal melanocytoma: A case report | Brain Tumor Pathology | 2003 | 69 |
21 | Prevalence and clinicopathological features of H3.3 G34-mutant high-grade gliomas: a retrospective study of 411 consecutive glioma cases in a single institution | Brain Tumor Pathology | 2017 | 69 |
22 | Correlation of diagnostic yield of stereotactic brain biopsy with number of biopsy bits and site of the lesion | Brain Tumor Pathology | 2006 | 68 |
23 | Epithelioid glioblastoma arising from pleomorphic xanthoastrocytoma with the BRAF V600E mutation | Brain Tumor Pathology | 2014 | 68 |
24 | Histone deacetylase inhibitors such as sodium butyrate and trichostatin A inhibit vascular endothelial growth factor (VEGF) secretion from human glioblastoma cells | Brain Tumor Pathology | 2002 | 66 |
25 | Association between molecular alterations and tumor location and MRI characteristics in anaplastic gliomas | Brain Tumor Pathology | 2015 | 65 |
26 | Development of a robust and sensitive pyrosequencing assay for the detection of IDH1/2 mutations in gliomas | Brain Tumor Pathology | 2015 | 65 |
27 | Specific monoclonal antibodies against IDH1/2 mutations as diagnostic tools for gliomas | Brain Tumor Pathology | 2015 | 62 |
28 | Aberrant methylation of genes in low-grade astrocytomas | Brain Tumor Pathology | 2000 | 59 |
29 | A miR-21 inhibitor enhances apoptosis and reduces G2-M accumulation induced by ionizing radiation in human glioblastoma U251 cells | Brain Tumor Pathology | 2011 | 58 |
30 | Clinicopathological study of pineal parenchymal tumors: correlation between histopathological features, proliferative potential, and prognosis | Brain Tumor Pathology | 1999 | 57 |
31 | Matrix metalloproteinase-2 and-9 expression in astrocytic tumors | Brain Tumor Pathology | 2003 | 55 |
32 | High expression of L-type amino acid transporter 1 in infiltrating glioma cells | Brain Tumor Pathology | 2005 | 55 |
33 | Glioma-initiating cells and molecular pathology: implications for therapy | Brain Tumor Pathology | 2011 | 55 |
34 | Expression of fascin, an actin-bundling protein, in astrocytomas of varying grades | Brain Tumor Pathology | 2003 | 54 |
35 | Nestin expression in brain tumors: its utility for pathological diagnosis and correlation with the prognosis of high-grade gliomas | Brain Tumor Pathology | 2012 | 54 |
36 | Glioneuronal tumors of the central nervous system | Brain Tumor Pathology | 2002 | 52 |
37 | CXCL12/CXCR4 signaling in malignant brain tumors: a potential pharmacological therapeutic target | Brain Tumor Pathology | 2011 | 52 |
38 | Presurgical mapping with magnetic source imaging: comparisons with intraoperative findings | Brain Tumor Pathology | 2000 | 51 |
39 | Pathological and clinical features of cystic and noncystic glioblastomas | Brain Tumor Pathology | 2006 | 51 |
40 | Primary diffuse leptomeningeal glioneuronal tumors | Brain Tumor Pathology | 2015 | 51 |
41 | Genetic analysis of human glioblastomas using a genomic microarray system | Brain Tumor Pathology | 2004 | 50 |
42 | Lymphocytic infundibulo-neurohypophysitis and infundibulo-panhypophysitis regarded as lymphocytic hypophysitis variant | Brain Tumor Pathology | 2008 | 50 |
43 | Precise comparison of protoporphyrin IX fluorescence spectra with pathological results for brain tumor tissue identification | Brain Tumor Pathology | 2011 | 50 |
44 | Expression of the multidrug-resistance P-glycoprotein (Pgp, MDR-1) by endothelial cells of the neovasculature in central nervous system tumors | Brain Tumor Pathology | 1999 | 49 |
45 | Immunohistochemical analysis of adhesion molecules and matrix metalloproteinases in malignant CNS lymphomas: a study comparing primary CNS malignant and CNS intravascular lymphomas | Brain Tumor Pathology | 2008 | 49 |
46 | Nestin expression in astrocytic tumors delineates tumor infiltration | Brain Tumor Pathology | 2010 | 48 |
47 | Characteristics of glioma stem cells | Brain Tumor Pathology | 2013 | 48 |
48 | Calcification on CT is a simple and valuable preoperative indicator of 1p/19q loss of heterozygosity in supratentorial brain tumors that are suspected grade II and III gliomas | Brain Tumor Pathology | 2016 | 48 |
49 | MicroRNA and extracellular vesicles in glioblastoma: small but powerful | Brain Tumor Pathology | 2016 | 47 |
50 | Immunohistochemistry on IDH 1/2, ATRX, p53 and Ki-67 substitute molecular genetic testing and predict patient prognosis in grade III adult diffuse gliomas | Brain Tumor Pathology | 2016 | 47 |